Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01686087 · ClinicalTrials.gov registry record · NA
Attaining and Maintaining Wellness in Obsessive-compulsive Disorder
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT01686087 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 137 participants.
The verdict
NCT01686087, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
The goal of this study is to understand whether patients with obsessive-compulsive disorder (OCD) on serotonin reuptake inhibitors (SRIs) who receive a type of Cognitive-behavioral therapy called Exposure and Ritual Prevention (EX/RP) can discontinue their medication if they first do well with EX/RP.
Interventions
- BEHAVIORAL Monthly Booster Sessions of EX/RP
- PROCEDURE Visits with MD and independent evaluators
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2012-10 |
| Est. Completion | 2018-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01686087
The ClinicalTrials.gov registry entry for NCT01686087 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Monthly Booster Sessions of EX/RP is the first listed.
NCT01686087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01686087 about?
NCT01686087 is a clinical study titled "Attaining and Maintaining Wellness in Obsessive-compulsive Disorder". The goal of this study is to understand whether patients with obsessive-compulsive disorder (OCD) on serotonin reuptake inhibitors (SRIs) who receive a type of Cognitive-behavioral therapy called Exposure and Ritual Prevention (EX/RP) can discontinue their medication if they first do well with EX/RP...
What is the current status of trial NCT01686087?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2012-10. Estimated completion is 2018-07.
What interventions are being tested in trial NCT01686087?
The interventions under investigation include: Monthly Booster Sessions of EX/RP (BEHAVIORAL), Visits with MD and independent evaluators (PROCEDURE).
Who is sponsoring clinical trial NCT01686087?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.